Polsinelli Podcasts - FDA Denies Amgen Citizen Petition in Biosimilar Dispute
As we previously reported, on July 5, the Federal Circuit affirmed the district court’s grant of a preliminary injunction enjoining Apotex from launching its biosimilar version of Amgen’s Neulasta (pegfilgrastim) until it...more